Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

BACKGROUND: The present study analyzed the relationship between clinical features and the T790M mutation in non-small cell lung cancer (NSCLC) patients resistant to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment. METHODS: NSCLC patients with resistance to first-gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wen, He, Jing, Jin, Shi-Dai, Xu, Jing, Yu, Tong-Fu, Wang, Wei, Zhu, Quan, Dai, Hui, Wu, Hao, Liu, Yi-Qian, Shu, Yong-Qian, Guo, Ren-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850705/
https://www.ncbi.nlm.nih.gov/pubmed/31819477
http://dx.doi.org/10.2147/OTT.S220383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850705/
https://www.ncbi.nlm.nih.gov/pubmed/31819477
http://dx.doi.org/10.2147/OTT.S220383

Ejemplares similares